ARTICLES
Minister Sussan Ley announces Review of the MBS
Last month the Minister for Health Sussan Ley MP announced a comprehensive review of the 5500 items on the Medical Benefits Schedule (MBS). The review will be ‘clinician led’ and be charged with identifying areas of inefficiency and ineffectiveness. According to the...
REIMBURSEMENT UNRAVELLED: Australia’s schizophrenic device coverage system
Sarah Grifffin, Principal of Medtechnique Consulting recently was invited to contribute to ‘Clinica’. Here is a link where you can read the article ‘REIMBURSEMENT UNRAVELLED: Australia’s schizophrenic device coverage system’. Read More This article was first...
Free Webinar on Australian Reimbursement for Medical Devices
The True Costs (and benefits) of Market Entry Tuesday April 21 2015 9.00am-10am PDT (Pacific Time US and Canada) Hosted by our Partner Organisation Brandwood Biomedical, Sarah Griffin, Principal of Medtechnique Consulting will outline the complexities of device...
Is your medical technology an inexpensive alternative to an implantable device? How do you access the Australian market?
Increasingly medical technology innovators are developing devices that are inexpensive alternatives to implantable devices. These devices can be a fraction of the cost of implantable devices yet there are hurdles to accessing the Australian market despite the cost...
Physician Reimbursement In Australia – Medical Services Advisory Committee (MSAC) Chair recommends early engagement for sponsors of new technologies
At a recent medical technology industry meeting Professor Robyn Ward, Chair of the Medical Services Advisory Committee (MSAC) recommended that sponsors of new and innovative technology seek early engagement with the Committee Secretariat. MSAC advises the Australian...
Who is going to pay for your new medical technology in Australia?
It is often surprising at how much thought is given to registering a device in Australia and how little is given to who would be the potential payers once the device or technology reached the market. Access to reimbursement or payment is critical to commercial...
Experts in medical device reimbursement and market access in Australia